Investors

Announcements

2023

Further re AGM

31 October 2022

TruSpine Technologies plc (AQSE: TSP), the medical device company focused on the development of its pioneering "screwless," spinal (vertebral) stabilisation systems, announces that, further to the announcement released on 27 October 2022, its Annual General Meeting ("AGM") was adjourned until further notice. The adjournment was approved by way of a majority shareholder vote present at the AGM, through a show of hands, and without any business being conducted. 

 

Enquiries:

Truspine Technologies Plc

Tel: +44 (0)20 3638 5025

Ian Roberts, CEO

 

 

 

Cairn Financial Advisers LLP (AQSE Corporate Adviser)

Tel: +44 (0)20 7213 0880

Liam Murray / Ludovico Lazzaretti

 

  

Oberon Capital (Joint Broker)

Tel: +44 (0)20 3179 5300

Mike Seabrook / Chris Crawford

 


Peterhouse Capital Limited (Joint Broker & Financial Adviser)

Lucy Williams / Duncan Vasey

Tel: +44 (0)20 7469 0930



Walbrook PR (Financial PR & IR)

Tel: +44 (0) 20 7933 7870 or +44 (0) 7876 741 001

Anna Dunphy

[email protected]

2022

Further re AGM

31 October 2022

TruSpine Technologies plc (AQSE: TSP), the medical device company focused on the development of its pioneering "screwless," spinal (vertebral) stabilisation systems, announces that, further to the announcement released on 27 October 2022, its Annual General Meeting ("AGM") was adjourned until further notice. The adjournment was approved by way of a majority shareholder vote present at the AGM, through a show of hands, and without any business being conducted. 

 

Enquiries:

Truspine Technologies Plc

Tel: +44 (0)20 3638 5025

Ian Roberts, CEO

 

 

 

Cairn Financial Advisers LLP (AQSE Corporate Adviser)

Tel: +44 (0)20 7213 0880

Liam Murray / Ludovico Lazzaretti

 

  

Oberon Capital (Joint Broker)

Tel: +44 (0)20 3179 5300

Mike Seabrook / Chris Crawford

 


Peterhouse Capital Limited (Joint Broker & Financial Adviser)

Lucy Williams / Duncan Vasey

Tel: +44 (0)20 7469 0930



Walbrook PR (Financial PR & IR)

Tel: +44 (0) 20 7933 7870 or +44 (0) 7876 741 001

Anna Dunphy

[email protected]

2021

Further re AGM

31 October 2022

TruSpine Technologies plc (AQSE: TSP), the medical device company focused on the development of its pioneering "screwless," spinal (vertebral) stabilisation systems, announces that, further to the announcement released on 27 October 2022, its Annual General Meeting ("AGM") was adjourned until further notice. The adjournment was approved by way of a majority shareholder vote present at the AGM, through a show of hands, and without any business being conducted. 

 

Enquiries:

Truspine Technologies Plc

Tel: +44 (0)20 3638 5025

Ian Roberts, CEO

 

 

 

Cairn Financial Advisers LLP (AQSE Corporate Adviser)

Tel: +44 (0)20 7213 0880

Liam Murray / Ludovico Lazzaretti

 

  

Oberon Capital (Joint Broker)

Tel: +44 (0)20 3179 5300

Mike Seabrook / Chris Crawford

 


Peterhouse Capital Limited (Joint Broker & Financial Adviser)

Lucy Williams / Duncan Vasey

Tel: +44 (0)20 7469 0930



Walbrook PR (Financial PR & IR)

Tel: +44 (0) 20 7933 7870 or +44 (0) 7876 741 001

Anna Dunphy

[email protected]

2020

Further re AGM

31 October 2022

TruSpine Technologies plc (AQSE: TSP), the medical device company focused on the development of its pioneering "screwless," spinal (vertebral) stabilisation systems, announces that, further to the announcement released on 27 October 2022, its Annual General Meeting ("AGM") was adjourned until further notice. The adjournment was approved by way of a majority shareholder vote present at the AGM, through a show of hands, and without any business being conducted. 

 

Enquiries:

Truspine Technologies Plc

Tel: +44 (0)20 3638 5025

Ian Roberts, CEO

 

 

 

Cairn Financial Advisers LLP (AQSE Corporate Adviser)

Tel: +44 (0)20 7213 0880

Liam Murray / Ludovico Lazzaretti

 

  

Oberon Capital (Joint Broker)

Tel: +44 (0)20 3179 5300

Mike Seabrook / Chris Crawford

 


Peterhouse Capital Limited (Joint Broker & Financial Adviser)

Lucy Williams / Duncan Vasey

Tel: +44 (0)20 7469 0930



Walbrook PR (Financial PR & IR)

Tel: +44 (0) 20 7933 7870 or +44 (0) 7876 741 001

Anna Dunphy

[email protected]